Apoptosis research has recently experienced a change from a paradigm in whi
ch the nucleus determined the apoptotic process to a paradigm in which casp
ases and, more recently, mitochondria constitute the center of death contro
l. Mitochondria undergo major changes in membrane integrity before classica
l signs of cell death become manifest. These changes concern both the inner
and the outer mitochondrial membranes, leading to the dissipation of the i
nner transmembrane potential (Delta Psi(m)) and/or the release of intermemb
rane proteins through the outer membrane. An ever-increasing number of endo
genous, viral, or xenogeneic effecters directly act on mitochondria to trig
ger permeabilization. At least in some cases, this is achieved by a direct
action on the permeability transition pore complex (PTPC), a multiprotein e
nsemble containing proteins from both mitochondrial membranes, which intera
ct with pro- and antiapoptotic members of the Bcl-2 family. At present, it
is elusive whether opening of the PTPC is the only physiological mechanism
leading to mitochondrial membrane permeabilization. Proteins released from
mitochondria during apoptosis include caspases (mainly caspases 2, 3, and 9
), caspase activators (cytochrome c, hsp 10), as well as a caspase-independ
ent death effector, AIF (apoptosis inducing factor). The functional hierarc
hy among these proteins and their actual impact on the decision between dea
th and life is elusive. (C) 2000 Academic Press.